Taking medications as prescribed (daily for liraglutide
The tumor-targeting ability of LAAM GSH-CQDs, which selectively penetrate tumor cells but rarely penetrate normal cells, results in a higher DOX concentration in tumor cells with enhanced cell toxicity and reduced toxicity to normal cells
R.CarlingD.MurphyK
This is possible without furthering, often lessening, the side effect profile of GLP-1 RA
Peptide Vials (Tirzepatide, 15 mg each): 8 weeks (2.55 mg/wk): ~30 mg total 2 vials 12 weeks (2.57.5 mg/wk): ~60 mg total 4 vials 16 weeks (2.510 mg/wk): ~100 mg total 7 vials Insulin Syringes (U100, 1 mL): 8 weeks: 8 syringes (1/week) 12 weeks: 12 syringes (1/week) 16 weeks: 20 syringes (1/week wks 112, 2/week wks 1316) Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution

Features could include: Realistic, achievable goal-setting with clear routines for positive habit formation, movement, hydration, nutrition, and mental health Personalized meal & exercise plans tailored to the GLP-1 medication, patients goals, lifestyle, and progress Interventions based on CBT to keep up motivation, help prevent relapses, and avoid emotional eating Integration of data from leading health apps Real-world evidence of patient outcomes In addition to supporting patients in achieving sustainable weight loss, a GLP-1 support app could provide pharma companies with structured, clinically meaningful data on treatment journeys and experience